Physician profile
Stanley A Gall
NPI 1982633467
$4,482.45
in general payments reported to CMS, 2019-2025
12 companies · $2,298 in 2025
The $2,298 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.01 · 2020: $31.99 · 2021: $110 · 2022: $180 · 2023: $634 · 2024: $1,196 · 2025: $2,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,105 · Food and Beverage: $2,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,104.99 |
| Food and Beverage | $2,023.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,636.66 | 2021-2025 | Mitraclip, Triclip, Epic |
| Edwards Lifesciences Corporation | $845.32 | 2020-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Atricure, INC. | $472.06 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $269.52 | 2022-2025 | Lifevest |
| Artivion, INC. | $80.25 | 2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical, Bioglue Surgical Adhesive |
| Lemaitre Vascular, INC. | $39.94 | 2022-2023 | Xenosure Biologic Patch |
| Boston Scientific Corporation | $39.03 | 2025 | General - Structural Heart |
| Medtronic, INC. | $36.55 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.85 | 2019 | |
| Getinge USA Sales, LLC | $17.60 | 2025 | Vasoview Hemopro 2 |
| Medtronic Vascular, INC. | $14.16 | 2019 | |
| Masimo Corporation | $13.51 | 2023 | Set and Rainbow Set |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Gall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.